Biologics Documents

This document serves as a comprehensive guide for CBER staff on proper naming conventions for biological and drug products. It includes policies, procedures, and definitions related to product naming and suffix assignment. Designed for regulatory compliance, it is essential for stakeholders in biopharmaceuticals.